• At A Glance
  • Hospital Affiliations

    I am thrilled to join Rutgers Cancer Institute of New Jersey (CINJ) as the Associate Director for Clinical Services, Medical Director of the Oncology Service Line for RWJBarnabas Health, and Director of the Lymphoma Program. Rutgers Cancer Institute is unique in that it is New Jersey’s only National Cancer Institute-designated Comprehensive Cancer Center. Our mission is to deliver integrated cancer care across the health system with access to academic expertise and innovative cancer therapies not available elsewhere in the state.

    Most recently, I served as the director of the Cancer Center at Tufts Medical Center in Boston, chief of their division of hematology/oncology and appointed as Professor of Medicine at Tufts University School of Medicine. I completed my fellowship in hematology/oncology at Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center in Chicago, Illinois, where I also remained as a faculty member. 

    My clinical expertise and research interests are dedicated to the field of lymphoma (i.e., Hodgkin lymphoma and non-Hodgkin lymphoma). Over the past 15 years, I have been the principal investigator of more than 75 national and international cancer clinical trials that have included phase I, II, and III studies, many which have been “investigator-initiated” trials studying new and novel targeted agents for the treatment of lymphoma. In addition to my clinical research, I also run a translational laboratory studying the biology of lymphoma and to discover new and novel treatments for patients, which has been continuously funded by the National Institutes of Health (NIH) and the NCI. This has resulted in 200+ research abstracts at national and international cancer research symposiums, as well as book chapters and 150+ manuscripts in peer-reviewed publications with an emphasis on the biology, prognosis, and treatment of lymphoma.

    My involvement in the advancement of cancer research has also included leadership roles in academic journals and international committees. I am an associate editor for the British Journal of Haematology and serve on the editorial board for the Journal of Clinical Oncology. I am a core member of the Hodgkin Lymphoma Working Group for the NIH/NCI Steering Committee and I have been a member of several additional clinical and scientific committees for the NIH, NCI, Cancer Therapy Evaluation Program (CTEP), Food and Drug Administration (FDA) and the ECOG/ACRIN group.  I am also honored to be a member of the Scientific Advisory Board for the Lymphoma Research Foundation (LRF) and am involved in a number of regional, national, and international educational forums and events.

    Rutgers Cancer Institute has a rich history of conducting innovative and groundbreaking cancer research and offers, together with RWJBarnabas Health, unparalleled knowledge, clinical care and resources for cancer patients and their families close to home.  Altogether, I am honored to join Rutgers Cancer Institute and work alongside the multitude of cancer providers providing exceptional and compassionate care right here in New Jersey.  

    Clinical Interests

    Hodgkin lymphoma, non-Hodgkin lymphoma (all types), chronic lymphocytic leukemia, and autologous hematopoietic stem cell (or bone marrow) transplantation